Unlike in the parent cells, phosphorylation of KIT or PDGFRA or its downstream intermediates such as AKT, and the non-receptor tyrosine kinase Src in imatinib-resistant GIST cell lines remained unchanged even in the presence of imatinib. Here, KIT is linked to gastrointestinal stromal tumor.